| Year |
Citation |
Score |
| 2024 |
Yoon SB, Chen L, Robinson IE, Khatib TO, Arthur RA, Claussen H, Zohbi NM, Wu H, Mouw JK, Marcus AI. Subpopulation commensalism promotes Rac1-dependent invasion of single cells via laminin-332. The Journal of Cell Biology. 223. PMID 38551497 DOI: 10.1083/jcb.202308080 |
0.353 |
|
| 2023 |
Koo J, Seong CS, Parker RE, Dwivedi B, Arthur RA, Dinasarapu AR, Johnston HR, Claussen H, Tucker-Burden C, Ramalingam SS, Fu H, Zhou W, Marcus AI, Gilbert-Ross M. Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer. Biorxiv : the Preprint Server For Biology. PMID 37398244 DOI: 10.1101/2023.06.14.544941 |
0.372 |
|
| 2023 |
Seong CS, Huang C, Boese AC, Hou Y, Koo J, Mouw JK, Rupji M, Joseph G, Johnston HR, Claussen H, Switchenko JM, Behera M, Churchman M, Kolesar JM, Arnold SM, ... ... Marcus AI, et al. Loss of the endocytic tumor suppressor HD-PTP phenocopies LKB1 and promotes RAS-driven oncogenesis. Biorxiv : the Preprint Server For Biology. PMID 36747658 DOI: 10.1101/2023.01.26.525772 |
0.311 |
|
| 2021 |
Mao K, Liu F, Liu X, Khuri FR, Marcus AI, Li M, Zhou W. Corrigendum to "Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression" [Lung Cancer 88/2 (2015) 131-138]. Lung Cancer (Amsterdam, Netherlands). PMID 33618911 DOI: 10.1016/j.lungcan.2021.02.013 |
0.317 |
|
| 2021 |
Liu F, Liu Y, Liu X, Mao K, Zhong D, Marcus AI, Khuri FR, Sun SY, He Y, Zhou W. Corrigendum to "Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer" [Lung Cancer 123 (2018) 36-43]. Lung Cancer (Amsterdam, Netherlands). PMID 33612293 DOI: 10.1016/j.lungcan.2021.02.012 |
0.35 |
|
| 2020 |
Jin R, Liu B, Liu X, Fan Y, Peng W, Huang C, Marcus AI, Sica GL, Gilbert-Ross M, Liu Y, Zhou W. Leflunomide suppresses the growth of LKB1-inactivated tumors in the immunocompetent host and attenuates distant cancer metastasis. Molecular Cancer Therapeutics. PMID 33293343 DOI: 10.1158/1535-7163.MCT-20-0567 |
0.367 |
|
| 2020 |
Summerbell ER, Mouw JK, Bell JSK, Knippler CM, Pedro B, Arnst JL, Khatib TO, Commander R, Barwick BG, Konen J, Dwivedi B, Seby S, Kowalski J, Vertino PM, Marcus AI. Epigenetically heterogeneous tumor cells direct collective invasion through filopodia-driven fibronectin micropatterning. Science Advances. 6: eaaz6197. PMID 32832657 DOI: 10.1126/Sciadv.Aaz6197 |
0.41 |
|
| 2020 |
Pedro B, Rupji M, Dwivedi B, Kowalski J, Konen JM, Owonikoko TK, Ramalingam SS, Vertino PM, Marcus AI. Prognostic significance of an invasive leader cell-derived mutation cluster on chromosome 16q. Cancer. PMID 32315457 DOI: 10.1002/Cncr.32903 |
0.382 |
|
| 2019 |
Birmingham KG, O'Melia MJ, Ban D, Mouw J, Edwards EE, Marcus AI, McDonald J, Thomas SN. Analyzing Mechanisms of Metastatic Cancer Cell Adhesive Phenotype Leveraging Preparative Adhesion Chromatography Microfluidic. Advanced Biosystems. 3: e1800328. PMID 32627398 DOI: 10.1002/adbi.201800328 |
0.306 |
|
| 2019 |
Zoeller EL, Pedro B, Konen J, Dwivedi B, Rupji M, Sundararaman N, Wang L, Horton JR, Zhong C, Barwick BG, Cheng X, Martinez ED, Torres MP, Kowalski J, Marcus AI, et al. Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes. Journal of Cell Science. PMID 31515279 DOI: 10.1242/Jcs.231514 |
0.384 |
|
| 2019 |
Owonikoko TK, Zhang G, Lallani SB, Chen Z, Martinson DE, Khuri FR, Lonial S, Marcus A, Sun SY. Evaluation of preclinical efficacy of everolimus and pasireotide in thyroid cancer cell lines and xenograft models. Plos One. 14: e0206309. PMID 30807575 DOI: 10.1371/Journal.Pone.0206309 |
0.388 |
|
| 2019 |
Burton LJ, Koo J, Tucker-Burden C, Zhou W, Gilbert-Ross M, Huang C, Sica G, Marcus A. Abstract 865: Isolation of circulating tumors cells from genetically engineered mouse models of lung adenocarcinoma Cancer Research. 79: 865-865. DOI: 10.1158/1538-7445.Am2019-865 |
0.459 |
|
| 2019 |
Shoemaker JT, Richardson KR, Arnst J, Marcus A, Vukasinovic J. Abstract 54: Characterization of patient-derived organoids cultured on a gas-rich, liquid-liquid interface Cancer Research. 79: 54-54. DOI: 10.1158/1538-7445.Am2019-54 |
0.354 |
|
| 2019 |
Jin R, Liu X, Peng W, Fan Y, Liu B, Yang S, Xing C, Gilbert-Ross M, Marcus A, Zhou W. Abstract 4838: Leflunomide inhibits the growth of LKB1-inactivated tumors in both xenograft and immunocompetent genetically engineered mouse models Cancer Research. 79: 4838-4838. DOI: 10.1158/1538-7445.Am2019-4838 |
0.441 |
|
| 2019 |
Summerbell ER, Konen J, Kowalski J, Vertino P, Marcus A. Abstract 178: MYO10 aberrant methylation and overexpression in leader cells regulates lung cancer collective cell invasion and fibronectin patterning Cancer Research. 79: 178-178. DOI: 10.1158/1538-7445.Am2019-178 |
0.53 |
|
| 2019 |
Arnst J, Commander R, Marcus A. Abstract 1239: Structure activity relationship of alexidine analogs for the inhibition of collective invasion Cancer Research. 79: 1239-1239. DOI: 10.1158/1538-7445.Am2019-1239 |
0.507 |
|
| 2018 |
Liu F, Liu Y, Liu X, Mao K, Zhong D, Marcus AI, Khuri FR, Sun SY, He Y, Zhou W. Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 123: 36-43. PMID 30089593 DOI: 10.1016/j.lungcan.2018.06.026 |
0.371 |
|
| 2018 |
Haney S, Konen J, Marcus AI, Bazhenov M. The complex ecosystem in non small cell lung cancer invasion. Plos Computational Biology. 14: e1006131. PMID 29795571 DOI: 10.1371/Journal.Pcbi.1006131 |
0.405 |
|
| 2017 |
Richardson AM, Havel L, Koyen AE, Konen JM, Shupe JA, Wiles WG, Martin WD, Grossniklaus H, Sica GL, Gilbert-Ross M, Marcus A. Vimentin is required for lung adenocarcinoma metastasis via heterotypic tumor cell-cancer-associated fibroblast interactions during collective invasion. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29208669 DOI: 10.1158/1078-0432.Ccr-17-1776 |
0.375 |
|
| 2017 |
Konen J, Summerbell E, Dwivedi B, Galior K, Hou Y, Rusnak L, Chen A, Saltz J, Zhou W, Boise LH, Vertino P, Cooper L, Salaita K, Kowalski J, Marcus AI. Image-guided genomics of phenotypically heterogeneous populations reveals vascular signalling during symbiotic collective cancer invasion. Nature Communications. 8: 15078. PMID 28497793 DOI: 10.1038/Ncomms15078 |
0.461 |
|
| 2017 |
Li R, Ding C, Zhang J, Xie M, Park D, Ding Y, Chen G, Zhang G, Gilbert-Ross M, Zhou W, Marcus A, Sun SY, Chen ZG, Sica GL, Ramalingam SS, et al. Modulation of Bax and mTOR for cancer therapeutics. Cancer Research. PMID 28381544 DOI: 10.1158/0008-5472.Can-16-2356 |
0.39 |
|
| 2017 |
Gilbert-Ross M, Konen J, Koo J, Shupe J, Robinson BS, Wiles WG, Huang C, Martin WD, Behera M, Smith GH, Hill CE, Rossi MR, Sica GL, Rupji M, Chen Z, ... ... Marcus AI, et al. Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma. Jci Insight. 2: e90487. PMID 28289710 DOI: 10.1172/Jci.Insight.90487 |
0.35 |
|
| 2017 |
Li Z, Ivanov AA, Su R, Gonzalez-Pecchi V, Qi Q, Liu S, Webber P, McMillan E, Rusnak L, Pham C, Chen X, Mo X, Revennaugh B, Zhou W, Marcus A, et al. The OncoPPi network of cancer-focused protein-protein interactions to inform biological insights and therapeutic strategies. Nature Communications. 8: 14356. PMID 28205554 DOI: 10.1038/Ncomms14356 |
0.4 |
|
| 2017 |
Lee B, Konen J, Wilkinson S, Marcus AI, Jiang Y. Local alignment vectors reveal cancer cell-induced ECM fiber remodeling dynamics. Scientific Reports. 7: 39498. PMID 28045069 DOI: 10.1038/Srep39498 |
0.423 |
|
| 2017 |
Wei C, Achreja A, Konen J, Sica G, Gilbert-Ross M, Nagrath D, Marcus A, Shanmugam M. Abstract 4904: GLUT4 exhibits a non-canonical role of regulating lung cancer metastasis Cancer Research. 77: 4904-4904. DOI: 10.1158/1538-7445.Am2017-4904 |
0.475 |
|
| 2017 |
Li R, Ding C, Zhang J, Xie M, Park D, Ding Y, Chen G, Zhang G, Gilbert-Ross M, Zhou W, Marcus A, Sun S, Chen Z, Sica G, Ramalingam S, et al. Abstract 2333: Modulation of Bax and mTOR for cancer therapeutics Cancer Research. 77: 2333-2333. DOI: 10.1158/1538-7445.Am2017-2333 |
0.475 |
|
| 2017 |
Zoeller EL, Konen J, Bell J, Summerbell E, Kowalski J, Marcus A, Vertino P. Abstract 1962: Regulation of invasion by lysine demethylase 5B in non-small cell lung cancer cells Cancer Research. 77: 1962-1962. DOI: 10.1158/1538-7445.Am2017-1962 |
0.464 |
|
| 2016 |
Okura H, Golbourn BJ, Shahzad U, Agnihotri S, Sabha N, Krieger JR, Figueiredo CA, Chalil A, Landon-Brace N, Riemenschneider A, Arai H, Smith CA, Xu S, Kaluz S, Marcus AI, et al. A role for activated Cdc42 in glioblastoma multiforme invasion. Oncotarget. PMID 27486972 DOI: 10.18632/Oncotarget.10925 |
0.324 |
|
| 2016 |
De P, Carlson JH, Wu H, Marcus A, Leyland-Jones B, Dey N. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers. Oncotarget. PMID 27281609 DOI: 10.18632/Oncotarget.8988 |
0.411 |
|
| 2016 |
Konen J, Wilkinson S, Lee B, Fu H, Zhou W, Jiang Y, Marcus AI. LKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to drive collagen remodeling during invasion. Molecular Biology of the Cell. PMID 26864623 DOI: 10.1091/Mbc.E15-08-0569 |
0.437 |
|
| 2016 |
Coke CJ, Scarlett KA, Chetram MA, Jones KJ, Sandifer BJ, Davis AS, Marcus AI, Hinton CV. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveal a Mechanism for Regulation of Tumor Progression. The Journal of Biological Chemistry. PMID 26841863 DOI: 10.1074/jbc.M115.712661 |
0.301 |
|
| 2016 |
Konen J, Summerbell E, Galior K, Dwivedi B, Salaita K, Kowalski J, Marcus A. Abstract LB-355: Image-guided genomics reveals a symbiotic relationship between heterogeneous phenotypes in collective cancer invasion Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-355 |
0.504 |
|
| 2016 |
Gilbert-Ross M, Konen J, Koo J, Shupe J, Sica GL, Chen Z, Robinson BS, Behera M, Rossi MR, Smith GH, Hill CE, Ramalingam SM, Fu H, Khuri FR, Zhou W, ... Marcus A, et al. Abstract LB-348: Developing a personalized anti-metastatic therapy to treat KRAS, LKB1-mutant lung adenocarcinoma Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-348 |
0.486 |
|
| 2015 |
Liu F, Jin R, Liu X, Huang H, Wilkinson SC, Zhong D, Khuri FR, Fu H, Marcus A, He Y, Zhou W. LKB1 promotes cell survival by modulating TIF-IA-mediated pre-ribosomal RNA synthesis under uridine downregulated conditions. Oncotarget. PMID 26506235 DOI: 10.18632/Oncotarget.6224 |
0.403 |
|
| 2015 |
Mao K, Liu F, Liu X, Khuri FR, Marcus AI, Li M, Zhou W. Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression. Lung Cancer (Amsterdam, Netherlands). 88: 131-8. PMID 25769882 DOI: 10.1016/j.lungcan.2015.02.017 |
0.374 |
|
| 2015 |
Taliaferro-Smith L, Oberlick E, Liu T, McGlothen T, Alcaide T, Tobin R, Donnelly S, Commander R, Kline E, Nagaraju GP, Havel L, Marcus A, Nahta R, O'Regan R. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells. Oncotarget. 6: 4757-72. PMID 25749031 DOI: 10.18632/Oncotarget.3023 |
0.458 |
|
| 2015 |
Havel LS, Kline ER, Salgueiro AM, Marcus AI. Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity. Oncogene. 34: 1979-90. PMID 24858039 DOI: 10.1038/Onc.2014.123 |
0.454 |
|
| 2014 |
Zhou W, Zhang J, Marcus AI. LKB1 Tumor Suppressor: Therapeutic Opportunities Knock when LKB1 Is Inactivated. Genes & Diseases. 1: 64-74. PMID 25679014 DOI: 10.1016/J.Gendis.2014.06.002 |
0.417 |
|
| 2014 |
Antony ML, Lee J, Hahm ER, Kim SH, Marcus AI, Kumari V, Ji X, Yang Z, Vowell CL, Wipf P, Uechi GT, Yates NA, Romero G, Sarkar SN, Singh SV. Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of β-tubulin. The Journal of Biological Chemistry. 289: 1852-65. PMID 24297176 DOI: 10.1074/Jbc.M113.496844 |
0.371 |
|
| 2014 |
Mao K, Liu F, Liu X, He Y, Khuri F, Marcus A, Li M, Zhou W. Abstract 773: Restoration of LKB1 defect in EKVX cells leads to resistance to microtubule targeting agents Cancer Research. 74: 773-773. DOI: 10.1158/1538-7445.Am2014-773 |
0.475 |
|
| 2013 |
Yang Z, Garcia A, Xu S, Powell DR, Vertino PM, Singh S, Marcus AI. Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition. Plos One. 8: e75069. PMID 24069380 DOI: 10.1371/Journal.Pone.0075069 |
0.387 |
|
| 2013 |
Marcus AI, Khuri FR. Energizing the search to target LKB1-mutant tumors. Cancer Discovery. 3: 843-5. PMID 23928772 DOI: 10.1158/2159-8290.CD-13-0296 |
0.368 |
|
| 2013 |
Zhou W, Marcus AI, Vertino PM. Dysregulation of mTOR activity through LKB1 inactivation. Chinese Journal of Cancer. 32: 427-33. PMID 23668926 DOI: 10.5732/Cjc.013.10086 |
0.322 |
|
| 2012 |
Eggers CM, Kline ER, Zhong D, Zhou W, Marcus AI. STE20-related kinase adaptor protein α (STRADα) regulates cell polarity and invasion through PAK1 signaling in LKB1-null cells. The Journal of Biological Chemistry. 287: 18758-68. PMID 22493453 DOI: 10.1074/jbc.M111.316422 |
0.33 |
|
| 2012 |
Havel LS, Marcus A. Abstract 5172: The role of vimentin in FAK-mediated cell adhesion and metastasis Cancer Research. 72: 5172-5172. DOI: 10.1158/1538-7445.Am2012-5172 |
0.526 |
|
| 2012 |
Taliaferro-Smith LD, Oberlick EM, Liu T, Adams A, Eggers C, Kline E, Nagaraju GP, Cohen C, Marcus A, O'Regan R. Abstract 342: Silencing of IGF1R induces mesenchymal-to-epithelial transition and inhibits the metastatic properties of triple negative breast cancer cells Cancer Research. 72: 342-342. DOI: 10.1158/1538-7445.Am2012-342 |
0.48 |
|
| 2012 |
Abreu E, Patel P, Kline E, Marcus A, Vertino P. Abstract 3246: TMS1 / ASC is critical for primary ciliogenesis and participates in cell migration Cancer Research. 72: 3246-3246. DOI: 10.1158/1538-7445.Am2012-3246 |
0.478 |
|
| 2011 |
Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, Marcus AI. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. International Journal of Cancer. Journal International Du Cancer. 129: 2744-55. PMID 21538350 DOI: 10.1002/Ijc.25938 |
0.383 |
|
| 2011 |
Thaiparambil JT, Bender L, Ganesh T, Kline E, Patel P, Liu Y, Tighiouart M, Vertino PM, Harvey RD, Garcia A, Marcus A. Abstract 822: Withaferin A inhibits breast cancer invasion and metastasis at subcytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation Cancer Research. 71: 822-822. DOI: 10.1158/1538-7445.Am2011-822 |
0.482 |
|
| 2011 |
Taliaferro-Smith L, Oberlick E, Liu T, Eggers C, Kline E, Nagaraju G, Marcus A, O'Regan R. P1-02-06: Silencing of IGF-1R Has Paradoxical Effects in Triple Negative Breast Cancer Phenotypes. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-02-06 |
0.404 |
|
| 2010 |
Marcus AI, Zhou W. LKB1 regulated pathways in lung cancer invasion and metastasis Journal of Thoracic Oncology. 5: 1883-1886. PMID 21102257 DOI: 10.1097/JTO.0b013e3181fbc28a |
0.403 |
|
| 2010 |
Kang S, Elf S, Lythgoe K, Hitosugi T, Taunton J, Zhou W, Xiong L, Wang D, Muller S, Fan S, Sun SY, Marcus AI, Gu TL, Polakiewicz RD, Chen ZG, et al. p90 ribosomal S6 kinase 2 promotes invasion and metastasis of human head and neck squamous cell carcinoma cells. The Journal of Clinical Investigation. 120: 1165-77. PMID 20234090 DOI: 10.1172/Jci40582 |
0.358 |
|
| 2010 |
Saba NF, Marcus A, Beitler JJ, Muller S, Eggers C, Grist W, Chen A, Chen Z, Shin DM, Khuri FR. Abstract 3744: Acetylated tubulin (AT) levels predicts response to TPF chemotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC) Cancer Research. 70: 3744-3744. DOI: 10.1158/1538-7445.Am10-3744 |
0.345 |
|
| 2009 |
Thaiparambil J, Bender L, Kline E, Ganesh T, Snyder J, Liotta D, Marcus A. Vimentin: A Novel Chemopreventive Target for Breast Cancer Metastasis. Cancer Research. 69: 5063-5063. DOI: 10.1158/0008-5472.Sabcs-09-5063 |
0.506 |
|
| 2008 |
Zhang S, Schafer-Hales K, Khuri FR, Zhou W, Vertino PM, Marcus AI. The tumor suppressor LKB1 regulates lung cancer cell polarity by mediating cdc42 recruitment and activity. Cancer Research. 68: 740-8. PMID 18245474 DOI: 10.1158/0008-5472.Can-07-2989 |
0.373 |
|
| Show low-probability matches. |